{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:25:18Z","timestamp":1762928718734,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.iac.2019.07.010","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T08:52:27Z","timestamp":1567241547000},"page":"573-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Asthma Self-management"],"prefix":"10.1016","volume":"39","author":[{"given":"Lisa","family":"Ulrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2018","series-title":"The global asthma Report 2018","author":"Innes","key":"10.1016\/j.iac.2019.07.010_bib1"},{"author":"Centers for Disease Control","key":"10.1016\/j.iac.2019.07.010_bib2"},{"author":"Centers for Disease Control","key":"10.1016\/j.iac.2019.07.010_bib3"},{"issue":"5 Suppl","key":"10.1016\/j.iac.2019.07.010_bib4","first-page":"S94","article-title":"Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007","volume":"120","author":"National Asthma Education and Prevention Program","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"author":"Global Initiative for Asthma","key":"10.1016\/j.iac.2019.07.010_bib5"},{"issue":"2","key":"10.1016\/j.iac.2019.07.010_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.anai.2014.05.017","article-title":"Management of acute loss of asthma control in the yellow zone: a practice parameter","volume":"113","author":"Dinakar","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2019.07.010_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12916-017-0823-7","article-title":"Systematic meta-review of supported self-management for asthma: a healthcare perspective","volume":"15","author":"Pinnock","year":"2017","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.iac.2019.07.010_bib8","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jaci.2018.02.001","article-title":"Effectiveness of indoor allergen reduction in asthma management: a systematic review","volume":"141","author":"Leas","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2019.07.010_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.anai.2015.08.005","article-title":"Effects of secondhand smoke exposure on asthma morbidity and health care utilization in children: a systematic review and meta-analysis","volume":"115","author":"Wang","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2019.07.010_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.chest.2018.10.005","article-title":"Secondhand exposure to aerosols from electronic nicotine delivery systems and asthma exacerbations among youth with asthma","volume":"155","author":"Bayly","year":"2019","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.iac.2019.07.010_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1081\/JAS-100107116","article-title":"The use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: a systematic review","volume":"38","author":"Aaron","year":"2001","journal-title":"J\u00a0Asthma"},{"issue":"1","key":"10.1016\/j.iac.2019.07.010_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ppul.1950080112","article-title":"Emergency management of the child with asthma","volume":"8","author":"Rubin","year":"1990","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.iac.2019.07.010_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1442-2026.2002.00308.x","article-title":"Patients with a longer duration of symptoms of acute asthma are more likely to require admission to hospital","volume":"14","author":"Kelly","year":"2002","journal-title":"Emerg Med (Fremantle)"},{"issue":"12","key":"10.1016\/j.iac.2019.07.010_bib16","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/ppul.23892","article-title":"Home supply of emergency oral steroids and reduction in asthma healthcare utilization","volume":"52","author":"Sarzynski","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.iac.2019.07.010_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaci.2016.06.054","article-title":"Acute asthma, prognosis, and treatment","volume":"139","author":"Fergeson","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2019.07.010_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.iac.2016.03.013","article-title":"Traditional therapies for severe asthma","volume":"36","author":"Wang","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"year":"2018","author":"Sobieraj","key":"10.1016\/j.iac.2019.07.010_bib20"},{"issue":"6","key":"10.1016\/j.iac.2019.07.010_bib21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jaci.2008.09.029","article-title":"Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing","volume":"122","author":"Bacharier","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2019.07.010_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0808907","article-title":"Preemptive use of high-dose fluticasone for virus-induced wheezing in young children","volume":"360","author":"Ducharme","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iac.2019.07.010_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1651-2227.1999.tb01266.x","article-title":"Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers","volume":"88","author":"Svedmyr","year":"1999","journal-title":"Acta Paediatr"},{"issue":"21","key":"10.1016\/j.iac.2019.07.010_bib24","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1056\/NEJMoa1104647","article-title":"Daily or intermittent budesonide in preschool children with recurrent wheezing","volume":"365","author":"Zeiger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.iac.2019.07.010_bib25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa042552","article-title":"Daily versus as-needed corticosteroids for mild persistent asthma","volume":"352","author":"Boushey","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"9405","key":"10.1016\/j.iac.2019.07.010_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(03)15384-6","article-title":"Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial","volume":"363","author":"Harrison","year":"2004","journal-title":"Lancet"},{"issue":"7033","key":"10.1016\/j.iac.2019.07.010_bib27","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bmj.312.7033.748","article-title":"Randomised comparison of guided self management and traditional treatment of asthma over one year","volume":"312","author":"Lahdensuo","year":"1996","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.iac.2019.07.010_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200904-0616OC","article-title":"Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial","volume":"180","author":"Oborne","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.iac.2019.07.010_bib29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJMoa1714257","article-title":"Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations","volume":"378","author":"McKeever","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.iac.2019.07.010_bib30","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.2018.2769","article-title":"Association of inhaled corticosteroids and long-acting beta-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.iac.2019.07.010_bib31","first-page":"427","article-title":"Adjustable maintenance dosing with budesonide\/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study","volume":"10","author":"FitzGerald","year":"2003","journal-title":"Can Respir J"},{"issue":"2","key":"10.1016\/j.iac.2019.07.010_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/ACI.0000000000000512","article-title":"Management of acute loss of asthma control: yellow zone strategies","volume":"19","author":"Polk","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2019.07.010_bib33","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1378\/chest.130.6.1733","article-title":"Budesonide\/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma","volume":"130","author":"Bisgaard","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.iac.2019.07.010_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(13)70012-2","article-title":"Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial","volume":"1","author":"Papi","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"14","key":"10.1016\/j.iac.2019.07.010_bib36","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2018.2757","article-title":"Association of inhaled corticosteroids and long-acting muscarinic antagonists with asthma control in patients with uncontrolled, persistent asthma: a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.iac.2019.07.010_bib37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2016.01.011","article-title":"Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial","volume":"138","author":"Hamelmann","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2019.07.010_bib38","doi-asserted-by":"crossref","first-page":"e0124109","DOI":"10.1371\/journal.pone.0124109","article-title":"Long-term once-daily tiotropium respimat(R) is well tolerated and maintains efficacy over 52\u00a0weeks in patients with symptomatic asthma in japan: a randomised, placebo-controlled study","volume":"10","author":"Ohta","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.iac.2019.07.010_bib39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaip.2015.08.017","article-title":"The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial","volume":"4","author":"Paggiaro","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"year":"2018","series-title":"Spiriva\u00ae Respimat\u00ae (tiotropium bromide) inhalation spray [package insert]","key":"10.1016\/j.iac.2019.07.010_bib40"},{"issue":"8","key":"10.1016\/j.iac.2019.07.010_bib41","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2213-2600(14)70107-9","article-title":"The role of macrolides in asthma: current evidence and future directions","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.iac.2019.07.010_bib42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/ped.2016.0663","article-title":"Macrolides for acute wheezing episodes in preschool children","volume":"29","author":"Raissy","year":"2016","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"19","key":"10.1016\/j.iac.2019.07.010_bib43","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1001\/jama.2015.13896","article-title":"Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized clinical trial","volume":"314","author":"Bacharier","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.iac.2019.07.010_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-2600(15)00500-7","article-title":"Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years: a randomised, double-blind, placebo-controlled trial","volume":"4","author":"Stokholm","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.iac.2019.07.010_bib45","doi-asserted-by":"crossref","first-page":"e0182411","DOI":"10.1371\/journal.pone.0182411","article-title":"Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: a placebo-controlled randomized trial","volume":"12","author":"Mandhane","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.iac.2019.07.010_bib46","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/jamainternmed.2016.5664","article-title":"Azithromycin for acute exacerbations of asthma : The AZALEA randomized clinical trial","volume":"176","author":"Johnston","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.iac.2019.07.010_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1164\/rccm.200510-1546OC","article-title":"Short-course montelukast for intermittent asthma in children: a randomized controlled trial","volume":"175","author":"Robertson","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.iac.2019.07.010_bib49","article-title":"Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children","author":"Brodlie","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.iac.2019.07.010_bib50","article-title":"Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children","author":"Watts","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.iac.2019.07.010_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2466-13-20","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation","volume":"13","author":"Zubairi","year":"2013","journal-title":"BMC Pulm Med"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:43:33Z","timestamp":1760179413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856119300499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0889856119300499"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2019.07.010","relation":{},"ISSN":["0889-8561"],"issn-type":[{"type":"print","value":"0889-8561"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asthma Self-management","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2019.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}